Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Mechanism of action elucidated for anthracycline developed by Sumitomo

Oct. 27, 1997

TOP-53: preclinical antitumor activity and pharmacokinetics

Oct. 27, 1997

Photofrin now available in France and Germany

Oct. 24, 1997

MS-209 reverses MDR mediated by MRP and P-glycoprotein

Oct. 24, 1997

Synthetic retinoid with antiangiogenic/apoptosis-inducing effects from Taiho

Oct. 24, 1997

Taiho reports preclinical studies on TAS-103

Oct. 24, 1997

Preclinical studies on TZT-1027, an antitumor dolastatin 10 derivative

Oct. 24, 1997

NCA-0465: new antitumor indoloquinoxaline derivative

Oct. 24, 1997

Cellular target of new antitumor agent from Nippon Shinyaku identified

Oct. 24, 1997

Nikken presents new modulator of multidrug resistance

Oct. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...